AI Article Synopsis
- The discovery of extracellular vesicles (EVs) in mycobacterial species has revealed their critical roles in bacterial function and interactions with hosts, particularly in tuberculosis (TB).
- Recent findings indicate that Mycobacterium tuberculosis (the TB-causing agent) produces EVs containing diverse biomolecules that can modulate immune responses and may have vaccine potential.
- This minireview covers previous and new insights into the process of vesicle formation (vesiculogenesis), their content, and implications for understanding TB and developing diagnostic and therapeutic tools.
Article Abstract
Since the discovery of extracellular vesicles (EVs) in mycobacterial species 15 years back, we have learned that this phenomenon is conserved in the genus and has critical roles in bacterial physiology and host-pathogen interactions. (), the tuberculosis (TB) causative agent, produces EVs both and including a diverse set of biomolecules with demonstrated immunomodulatory effects. Moreover, EVs (MEVs) have been shown to possess vaccine properties and carry biomarkers with diagnostic capacity. Although information on MEV biogenesis relative to other bacterial species is scarce, recent studies have shed light on how MEVs originate and are released to the extracellular space. In this minireview, we discuss past and new information about the vesiculogenesis phenomenon in , including biogenesis, MEV cargo, aspects in the context of host-pathogen interactions, and applications that could help to develop effective tools to tackle the disease.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11077946 | PMC |
| http://dx.doi.org/10.1128/mbio.02552-23 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!